Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03190122
Other study ID # N-71-2016
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received May 10, 2017
Last updated June 15, 2017
Start date June 2017
Est. completion date April 2018

Study information

Verified date June 2017
Source Kasr El Aini Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date April 2018
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- preoptic meningioma, not recurrent, size is operative.

Exclusion Criteria:

- other meningiomas than preoptic , recurrent cases, size is not operative, other medical conditions affect the mental condition of the patient.

Study Design


Related Conditions & MeSH terms

  • Meningioma
  • Neurocognitive Outcome Assesment in Patients With Perioptic Meningiomas

Intervention

Procedure:
surgical excision of the tumor
Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial. [NCT ID not yet assigned]

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kasr El Aini Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Neurocognitive Outcome Assessment using MOCA scale aggregated by our researchers in data base system in our department. 1 year
Secondary Neurocognitive Outcome using neuropsychological assessment questionnaire aggregated by our researchers in data base system in our department. 1 year